| Autor: |
Amjad AI; Division of Hematology Oncology, Department of Medicine, University of Pittsburgh PA, USA., Singhi AD; Department of Pathology, University of Pittsburgh PA, USA., Balaban EP; Penn State Hershey Cancer Institute, Hershey PA, USA., Dudley B; Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh PA, USA., Brand RE; Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh PA, USA., Bahary N; Division of Hematology Oncology, Department of Medicine, University of Pittsburgh PA, USA ; Department of Molecular Genetics and Developmental Biology, University of Pittsburgh School of Medicine Pittsburgh, PA, USA. |
| Abstrakt: |
A 58 y/o male with Lynch syndrome, who was diagnosed with a squamous cell carcinoma (SCC) arising in the duodenum, is described. Previous malignancies included two metachronous colorectal adenocarcinomas, and a known family history of Lynch syndrome associated with deletion of exons 8-15 of the MSH2 gene. Analysis of his small bowel SCC revealed loss of MSH2 and MSH6 protein expression, suggesting a pathogenic role of the germ-line deletion. While small bowel adenocarcinomas have previously been reported in Lynch syndrome, to our knowledge this is the first report of Lynch syndrome-associated squamous histology. As patients with Lynch syndrome live longer with early detection and treatment of their cancers, unusual sites and histology of previously unreported cancers may emerge. It is also important to recognize variant histologies that otherwise might not prompt pursuing a diagnosis of Lynch syndrome in the appropriate clinical setting. |
